Staphylococcus aureus epidemiology, pathophysiology, clinical manifestations and application of nano-therapeutics as a promising approach to combat methicillin resistant Staphylococcus aureus

References

• Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547–569. doi: 10.1080/21505594.2021.1878688
   PubMed Web of Science ®Google Scholar
• Javid F, Taku A, Bhat MA, et al. Molecular typing of Staphylococcus aureus based on coagulase gene. Vet World. 2018 Apr;11(4):423–430. doi: 10.14202/vetworld.2018.423-430
   PubMed Web of Science ®Google Scholar
• Boswihi SS, Udo EE. Methicillin-resistant Staphylococcus aureus: an update on the epidemiology, treatment options and infection control. Curr Med Res Pract. 2018;8(1):18–24. InternetAvailable from: https://www.sciencedirect.com/science/article/pii/S2352081717301708. doi: 10.1016/j.cmrp.2018.01.001
   Google Scholar
• Linz MS, Mattappallil A, Finkel D, et al. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics. 2023;12(3):1–27. doi: 10.3390/antibiotics12030557
   Google Scholar
• Kayan T. Staphylococcus aureus Secreted Toxins & Extracellular Enzymes. Physiol Behav. 2017;176(3):139–148. doi: 10.1016/j.physbeh.2017.03.040
   PubMedGoogle Scholar
• Obee P, Griffith CJ, Cooper RA, et al. An evaluation of different methods for the recovery of meticillin-resistant Staphylococcus aureus from environmental surfaces. J Hosp Infect. 2007;65(1):35–41. doi: 10.1016/j.jhin.2006.09.010
   PubMed Web of Science ®Google Scholar
• Adhikari RP. Staphylococcal infections: host and pathogenic factors. Vol. 9. Microorganisms. Switzerland: MDPI AG; 2021. doi:10.3390/microorganisms9051080
   Google Scholar
• Ivanova N, Gugleva V, Dobreva M, et al. We are IntechOpen, the world ’ s leading publisher of open access books built by scientists, for scientists TOP 1 %. Intech. 2016;i(tourism):13.
   Google Scholar
• Missiakas DM, Schneewind O. Growth and laboratory maintenance of Staphylococcus aureus. CP Microbiol. 2013 Feb;28(1):Unit 9C.1. doi: 10.1002/9780471729259.mc09c01s28
   Google Scholar
• Reddy PN, Srirama K, Dirisala VR. An update on clinical Burden, diagnostic tools, and therapeutic options of Staphylococcus aureus. Infect Dis Res Treat. 2017;10:117991611770399. doi: 10.1177/1179916117703999
   Google Scholar
• Otto M. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol. 2010 Apr;5(2):183–195. doi: 10.1586/edm.10.6
   PubMedGoogle Scholar
• Luo Z, Yue S, Chen T, et al. Reduced growth of Staphylococcus aureus under high glucose conditions is associated with decreased pentaglycine expression. Front Microbiol. 2020;11:537290. doi: 10.3389/fmicb.2020.537290
   PubMed Web of Science ®Google Scholar
• Guo Y, Song G, Sun M, et al. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front Cell Infect Microbiol. 2020;10:107. doi: 10.3389/fcimb.2020.00107
   PubMed Web of Science ®Google Scholar
• Shankar P. Book review: tackling drug-resistant infections globally. Arch Pharma Pract. 2016;7(3):110. doi: 10.4103/2045-080X.186181
   Web of Science ®Google Scholar
• Chinemerem Nwobodo D, Ugwu MC, Oliseloke Anie C, et al. Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022 Sep;36(9):e24655. doi: 10.1002/jcla.24655
   PubMed Web of Science ®Google Scholar
• Ahmad-Mansour N, Loubet P, Pouget C, et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins (Basel). 2021;13(10):1–22. doi: 10.3390/toxins13100677
   Web of Science ®Google Scholar
• Martínez OF, Cardoso MH, Ribeiro SM, et al. Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol. 2019;9(APR). doi: 10.3389/fcimb.2019.00074
   Google Scholar
• Kim M-K. Staphylococcus aureus toxins: from their pathogenic roles to anti-virulence therapy using natural products. Biotechnol Bioprocess Eng. 2019;24(3):424–435. InternetAvailable from. doi: 10.1007/s12257-019-0059-9
   Web of Science ®Google Scholar
• Bennett MR, Thomsen IP. Epidemiological and clinical evidence for the role of toxins in S. aureus human disease. Toxins (Basel). 2020;12(6):1–20. doi: 10.3390/toxins12060408
   Web of Science ®Google Scholar
• Vlaeminck J, Raafat D, Surmann K, et al. Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia. Toxins (Basel). 2020;12(11):721. doi: 10.3390/toxins12110721
   PubMed Web of Science ®Google Scholar
• Ford CA, Hurford IM, Cassat JE. Antivirulence strategies for the treatment of Staphylococcus aureus infections: a mini review. Front Microbiol. 2021;11(January):1–10. doi: 10.3389/fmicb.2020.632706
   Google Scholar
• Ahmad AL-Fawares RWA O, Abdul F, Salah F, et al. Probiotic therapy: a survey of Middle eastern healthcare providers’ attitudes, ‎Beliefs, and practice patterns. J Appl Pharm Sci. 2023;13(10):1–9. doi: 10.7324/JAPS.2023.143603
   Google Scholar
• Gnanamani A, Hariharan P, Paul-Satyaseela M. Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach. Front Staphylococcus Aureus. 2017;4. doi:10.5772/67338
   Google Scholar
• Tong SYC, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–661. doi: 10.1128/CMR.00134-14
   PubMed Web of Science ®Google Scholar
• Wang H, Hou X, Shen J, et al. Alternative sigma factor B reduces biofilm formation and stress response in milk-derived Staphylococcus aureus. Lwt. 2022;162(October 2021):113515. InternetAvailable from. doi: 10.1016/j.lwt.2022.113515
   Google Scholar
• Sharma S, Mohler J, Mahajan SD, et al. Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms. 2023;11(6):1614. doi: 10.3390/microorganisms11061614
   PubMed Web of Science ®Google Scholar
• Shoaib M, Aqib AI, Muzammil I, et al. MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework. Front Microbiol. 2023;13(January): doi: 10.3389/fmicb.2022.1067284
   PubMedGoogle Scholar
• Amir N, Rossney A, Veale J, et al. Spread of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infection within a family: implications for antibiotic therapy and prevention. J Med Microbiol. 2010 Apr 1;59(4):489–492. doi: 10.1099/jmm.0.015925-0
   PubMed Web of Science ®Google Scholar
• O’Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev. 2004;17(1):218–234. doi: 10.1128/CMR.17.1.218-234.2004
   PubMed Web of Science ®Google Scholar
• Prosperi M, Azarian T, Johnson JA, et al. Unexpected predictors of antibiotic resistance in housekeeping genes of Staphylococcus aureus. ACM-BCB 2019 - Proc 10th ACM Int Conf Bioinformatics, Comput Biol Heal Informatics. 2019;259–268. doi: 10.1145/3307339.3342138
   Google Scholar
• Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17(4):203–218. doi: 10.1038/s41579-018-0147-4
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362–386. doi: 10.1128/CMR.05022-11
   PubMed Web of Science ®Google Scholar
• Hindy J-R, Quintero-Martinez JA, Lee AT, et al. Incidence trends and epidemiology of Staphylococcus aureus bacteremia: a systematic review of population-based studies. Cureus. 2022;14(5): doi: 10.7759/cureus.25460
   Web of Science ®Google Scholar
• Tsige Y, Tadesse S, G/Eyesus T, et al. Prevalence of methicillin-resistant Staphylococcus aureus and associated risk factors among patients with wound infection at referral hospital, Northeast Ethiopia. J Pathog. 2020;2020:1–7. doi: 10.1155/2020/3168325
   Web of Science ®Google Scholar
• Loftus MJ, Young-Sharma TEMW, Wati S, et al. Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: a prospective cohort study. Lancet Reg Health West Pac InternetAvailable from. 2022;22:100438. doi: 10.1016/j.lanwpc.2022.100438
   PubMedGoogle Scholar
• Tabaja H, Hindy JR, Kanj SS. EPIDEMIOLOGY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN ARAB COUNTRIES OF THE MIDDLE EAST AND NORTH AFRICAN REGION. Mediterr J Hematol Infect Dis. 2021;13(1):e2021050. doi: 10.4084/MJHID.2021.050
   PubMedGoogle Scholar
• Jarajreh D, Aqel A, Alzoubi H, et al. Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: the first study in Jordan. J Infect Dev Ctries. 2017;11(4):350–354. doi: 10.3855/jidc.8316
   PubMed Web of Science ®Google Scholar
• Moyo SJ, Aboud S, Blomberg B, et al. High nasal carriage of methicillin-resistant Staphylococcus aureus among healthy Tanzanian under-5 children. Microb Drug Resist. 2014;20(1):82–88. doi: 10.1089/mdr.2013.0016
   PubMed Web of Science ®Google Scholar
• Harbarth S, François P, Schrenzel J, et al. Community-associated methicillin-resistant Staphylococcus aureus , Switzerland. Emerg Infect Dis. 2005;11(6):962–965. doi: 10.3201/eid1106.041308
   PubMed Web of Science ®Google Scholar
• Belbase A, Pant ND, Nepal K, et al. Antibiotic resistance and biofilm production among the strains of Staphylococcus aureus isolated from pus/wound swab samples in a tertiary care hospital in Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):1–5. doi: 10.1186/s12941-017-0194-0
   PubMedGoogle Scholar
• Islam SI, Moore C. Prevalence of methicillin-resistant Staphyloccocus aureus and associated risk factors on admission to a specialist care eye hospital. Ann Saudi Med. 2002;22(3–4):153–157. doi: 10.5144/0256-4947.2002.153
   PubMed Web of Science ®Google Scholar
• Aqel AA, Ibrahim A, Shehabi A. Rare occurrence of mupirocin resistance among clinical Staphylococcus isolates in Jordan. Acta Microbiol Immunol Hung. 2012;59(2):239–247. doi: 10.1556/amicr.59.2012.2.8
   PubMed Web of Science ®Google Scholar
• Hasanpour AH, Sepidarkish M, Mollalo A, et al. The global prevalence of methicillin-resistant Staphylococcus aureus colonization in residents of elderly care centers: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2023;12(1):4. InternetAvailable from. doi: 10.1186/s13756-023-01210-6
   PubMed Web of Science ®Google Scholar
• Di Gregorio S, Vielma J, Haim MS, et al. Genomic epidemiology of Staphylococcus aureus isolated from bloodstream infections in South America during 2019 supports regional surveillance. Microb Genomics. 2023;9(5): doi: 10.1099/mgen.0.001020
   PubMed Web of Science ®Google Scholar
• Abdolmaleki Z, Mashak Z, Safarpoor Dehkordi F. Phenotypic and genotypic characterization of antibiotic resistance in the methicillin-resistant Staphylococcus aureus strains isolated from hospital cockroaches. Antimicrob Resist Infect Control. 2019;8(1):1–14. doi: 10.1186/s13756-019-0505-7
   PubMedGoogle Scholar
• Vinacke HM, Vinacke HM. International journal. Pacific Affairs. 1946;19(2):222. doi: 10.2307/2752507
   Google Scholar
• Pal M, Berhanu G, Megersa L, et al. Epidemiology, pathogenicity, animal infections, antibiotic resistance, public health significance, and economic impact of Staphylococcus aureus: a comprehensive review. Am J Public Heal Res. 2020;8(1):14–21.
   Google Scholar
• Hennekinne JA, De Buyser ML, Dragacci S. Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation. FEMS Microbiol Rev. 2012;36(4):815–836. doi: 10.1111/j.1574-6976.2011.00311.x
   PubMed Web of Science ®Google Scholar
• Akineden O, Hassan AA, Schneider E, et al. Enterotoxigenic properties of Staphylococcus aureus isolated from goats’ milk cheese. International Journal Of Food Microbiology. 2008;124(2):211–216. doi: 10.1016/j.ijfoodmicro.2008.03.027
   PubMed Web of Science ®Google Scholar
• Leung AKC, Barankin B, Leong KF. Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management. World J Pediatr. 2018;14(2):116–120. doi: 10.1007/s12519-018-0150-x
   PubMed Web of Science ®Google Scholar
• Brazel M, Desai A, Are A, et al. Staphylococcal scalded skin syndrome and bullous impetigo. Medicina. 2021;57(11):1157. doi: 10.3390/medicina57111157
   PubMedGoogle Scholar
• Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28(11):1418–1423. doi: 10.1111/jdv.12541
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Makiguchi T, Nakamura H, et al. Staphylococcal scalded skin syndrome caused by burn wound infection in an infant: a case report. Burns Open. 2018;2(3):139–143. doi: 10.1016/j.burnso.2018.05.003
   Google Scholar
• Poolman JT, Anderson AS. Escherichia coli and Staphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations. Expert Rev Vaccines. 2018;17(7):607–618. doi: 10.1080/14760584.2018.1488590
   PubMed Web of Science ®Google Scholar
• Nandhini P, Kumar P, Mickymaray S, et al. Recent developments in methicillin-resistant Staphylococcus aureus (MRSA) treatment: a review. Antibiotics. 2022;11(5):1–21. doi: 10.3390/antibiotics11050606
   Google Scholar
• Guaraná M, Nucci M, Nouér SA. EPIDEMIOLOGY, PREDISPOSING FACTORS and OUTCOME of STAPHYLOCOCCUS AUREUS BACTEREMIA in NEUTROPENIC PATIENTS. Hematol Transfus Cell Ther. 2022;44:S70–1. InternetAvailable from: https://www.sciencedirect.com/science/article/pii/S2531137922002334
   PubMedGoogle Scholar
• Nappi F, Singh SSA. Molecular pathways in Staphylococcus aureus endocarditis: a systematic review. Int. J. Mol. Sci. 2023;24(13):11068 doi: 10.3390/ijms241311068
   PubMed Web of Science ®Google Scholar
• Liesenborghs L, Meyers S, Lox M, et al. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves. Eur Heart J. 2019;40(39):3248–3259. doi: 10.1093/eurheartj/ehz175
   PubMed Web of Science ®Google Scholar
• Peña-Moreno A, Torres-Soblechero L, López-Blázquez M, et al. Fatal Staphylococcus aureus endocarditis misdiagnosed as multisystem inflammatory syndrome in children. Pediatr Infect Dis J. 2022;41(2):e58–e59. doi: 10.1097/INF.0000000000003417
   PubMed Web of Science ®Google Scholar
• Oryan A, Alidadi S, Moshiri A, et al. Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res. 2014 Mar;9(1):18. doi: 10.1186/1749-799X-9-18
   PubMed Web of Science ®Google Scholar
• Calhoun JH, Manring MM, Shirtliff M. Osteomyelitis of the long bones. Semin Plast Surg. 2009 May;23(2):059–072. doi: 10.1055/s-0029-1214158
   PubMedGoogle Scholar
• Gillet Y, Tristan A, Rasigade JP, et al. Prognostic factors of severe community-acquired staphylococcal pneumonia in France. Eur Respir J. 2021;58(5):1–13. InternetAvailable from. doi: 10.1183/13993003.04445-2020
   Web of Science ®Google Scholar
• Cone S, Mistretta V, Lambert N, et al. Community-acquired Staphylococcus aureus pneumonia. Revue Medicale de Liege Belgium. 2021;76:595–597.
   PubMedGoogle Scholar
• Kulkarni D, Wang X, Sharland E, et al. The global burden of hospitalisation due to pneumonia caused by Staphylococcus aureus in the under-5 years children: a systematic review and meta-analysis. EClinicalMedicine. 2022 Feb;44:101267. doi: 10.1016/j.eclinm.2021.101267
   PubMedGoogle Scholar
• Vraa EP. Atypical presentation of sepsis from community-acquired Staphylococcus aureus pneumonia in a previously healthy 47-year-old male: case report. J Emerg Crit Care Med. 2021;5:1–5. doi: 10.21037/jeccm-21-1
   Google Scholar
• Clark SB, Hicks MA. Staphylococcal Pneumonia. Treasure Island (FL). 2023.
   Google Scholar
• Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (London, England). 2002 Mar;359(9308):753–759. doi: 10.1016/S0140-6736(02)07877-7
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink R. Methicillin-resistant Staphylococcus aureus and community-acquired pneumonia: an evolving relationship. Clin Infect Dis. 54(8): InternetAvailable from:1134–1136. 2012 Apr 15. doi: 10.1093/cid/cis045
   PubMed Web of Science ®Google Scholar
• Wang Y, Sibaii F, Lee K, et al. NOTE: this preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1. medRxiv. 2021;1(165):1–13.
   Google Scholar
• Zhou Z, Charlesworth J, Achtman M. Accurate reconstruction of bacterial pan- and core genomes with PEPPAN. Genome Res. 2020 Nov;30(11):1667–1679. doi: 10.1101/gr.260828.120
   PubMed Web of Science ®Google Scholar
• Seder N, Rayyan WA, Al-Fawares O, et al. Pseudomonas aeruginosa virulence factors and Antivirulence mechanisms to combat drug resistance. A Systematic Review. 2022;56(December):1–23.
   Google Scholar
• Kläui AJ, Boss R, Graber HU, et al. Characterization and comparative analysis of the Staphylococcus aureus genomic island vSaβ: an in silico approach. J Bacteriol. 2019 Nov;201(22). doi: 10.1128/JB.00777-18
   PubMed Web of Science ®Google Scholar
• Patel H, Rawat S. A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis. Front Microbiol. 2023;14:14. doi: 10.3389/fmicb.2023.1204428
   Web of Science ®Google Scholar
• Cervera-Alamar M, Guzmán-Markevitch K, Žiemytė M, et al. Mobilisation mechanism of pathogenicity islands by endogenous phages in Staphylococcus aureus clinical strains. Sci Rep. 2018;8(1):1–13. doi: 10.1038/s41598-018-34918-2
   PubMedGoogle Scholar
• Kong C, Neoh H, Nathan S. Targeting Staphylococcus aureus toxins: a potential form of anti-virulence therapy. Vol. 8. Toxins: Multidisciplinary Digital Publishing Institute (MDPI); 2016.
   Google Scholar
• Missiakas DM, Schneewind O. Growth and laboratory maintenance of Staphylococcus aureus. Chapter 9. Curr Protoc Microbiol . 2013. p.Unit 9C.1.
   Google Scholar
• Chen Q, Zhao G, Yang W. Investigation into the prevalence of enterotoxin genes and genetic background of Staphylococcus aureus isolates from retain foods in Hangzhou, China. BMC Microbiol. 2023;23(1):1–19. doi: 10.1186/s12866-023-03027-0
   PubMed Web of Science ®Google Scholar
• Bernardos A, Piacenza E, Sancenón F, et al. Mesoporous silica-based materials with bactericidal properties. Small. 2019;15(24):1–34. doi: 10.1002/smll.201900669
   Web of Science ®Google Scholar
• Choudhary KS, Mih N, Monk J, et al. The Staphylococcus aureus two-component system AgrAC displays four distinct genomic arrangements that delineate genomic virulence factor signatures. Front Microbiol. 2018;9:1082. doi: 10.3389/fmicb.2018.01082
   PubMed Web of Science ®Google Scholar
• Joo HS, Chatterjee SS, Villaruz AE, et al. Mechanism of gene regulation by a staphylococcus aureus toxin. MBio. 2016;7(5):2016–2018. doi: 10.1128/mBio.01579-16
   Web of Science ®Google Scholar
• Jenul C, Horswill AR, Fischetti VA, et al. Regulation of Staphylococcus aureus Virulence. Microbiol Spectr. 2019 Apr;7(2). doi: 10.1128/microbiolspec.GPP3-0031-2018
   PubMed Web of Science ®Google Scholar
• Abdelnour A, Arvidson S, Bremell T, et al. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun. 1993;61(9):3879–3885. doi: 10.1128/iai.61.9.3879-3885.1993
   PubMed Web of Science ®Google Scholar
• Cheung GYC, Wang R, Khan BA, et al. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun. 2011;79(5):1927–1935. doi: 10.1128/IAI.00046-11
   PubMed Web of Science ®Google Scholar
• Al AA, Alsulami J, Aubee JI, et al. Staphylococcus aureus SigS induces expression of a regulatory protein pair that modulate its mRNA stability J. Bacteriol. 2022;205:e00392–22 doi: 10.1128/jb.00392-22
   Web of Science ®Google Scholar
• Cheung AL, Schmidt K, Bateman B, et al. SarS, a SarA homolog repressible by agr, is an activator of protein a synthesis in Staphylococcus aureus. Infect Immun. 2001 Apr;69(4):2448–2455. doi: 10.1128/IAI.69.4.2448-2455.2001
   PubMed Web of Science ®Google Scholar
• Tiwari N, López-Redondo M, Miguel-Romero L, et al. The SrrAB two-component system regulates Staphylococcus aureus pathogenicity through redox sensitive cysteines. Proc Natl Acad Sci. 2020;117(20):10989–10999. doi: 10.1073/pnas.1921307117
   PubMed Web of Science ®Google Scholar
• Balasubramanian D, Harper L, Shopsin B, et al. Staphylococcus aureus pathogenesis in diverse host environments. Pathog Dis. 2017 Feb 1;75(1): ftx005. InternetAvailable from. 10.1093/femspd/ftx005.
   PubMed Web of Science ®Google Scholar
• Johnson M, Sengupta M, Purves J, et al. Fur is required for the activation of virulence gene expression through the induction of the sae regulatory system in Staphylococcus aureus. Int J Med Microbiol. 2011 Jan 31;301(1):44–52. doi: 10.1016/j.ijmm.2010.05.003
   PubMed Web of Science ®Google Scholar
• Kinkel TL, Roux CM, Dunman PM, et al. The Staphylococcus aureus SrrAB two-component system promotes resistance to nitrosative stress and hypoxia. MBio. 2013;4(6):1–9. doi: 10.1128/mBio.00696-13
   Web of Science ®Google Scholar
• Gruber TM, Gross CA. Multiple sigma subunits and the partitioning of bacterial transcription space. Annu Rev Microbiol. 2003;57(1):441–466. doi: 10.1146/annurev.micro.57.030502.090913
   PubMedGoogle Scholar
• Shaw LN, Lindholm C, Prajsnar TK, et al. Identification and characterization of σS, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One. 2008 Dec 3;3(12): e3844. InternetAvailable from. 10.1371/journal.pone.0003844.
   PubMed Web of Science ®Google Scholar
• Bischoff M, Dunman P, Kormanec J, et al. Microarray-based analysis of the Staphylococcus aureus σB regulon. J Bacteriol. 2004;186(13):4085–4099. doi: 10.1128/JB.186.13.4085-4099.2004
   PubMed Web of Science ®Google Scholar
• Sinha D, Sinha D, Dutta A, et al. Alternative sigma factor of Staphylococcus aureus interacts with the cognate antisigma factor primarily using its domain 3. Biochemistry. 2021;60(2):135–151. doi: 10.1021/acs.biochem.0c00881
   PubMed Web of Science ®Google Scholar
• Wójcik-Bojek U, Różalska B, Sadowska B. Staphylococcus aureus—A known opponent against host defense mechanisms and vaccine development—do we still have a chance to win? Int J Mol Sci. 2022;23(2):948. doi: 10.3390/ijms23020948
   PubMed Web of Science ®Google Scholar
• Flannagan RS, Heit B, Heinrichs DE. Antimicrobial mechanisms of macrophages and the immune evasion strategies of Staphylococcus aureus. Pathogens. 2015;4(4):826–868. InternetAvailable from. doi: 10.3390/pathogens4040826
   PubMed Web of Science ®Google Scholar
• Shettigar K, Murali TS. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection. InternetAvailable from Eur J Clin Microbiol Infect Dis. 2020;39(12):2235–2246. doi: 10.1007/s10096-020-03984-8
   PubMed Web of Science ®Google Scholar
• Al-Bakri AG, Al-Hadithi H, Kasabri V, et al. The epidemiology and molecular characterization of methicillin-resistant staphylococci sampled from a healthy Jordanian population. Epidemiol Infect. 2013;141(11):2384–2391. doi: 10.1017/S0950268813000010
   PubMed Web of Science ®Google Scholar
• Mansour Albalbaki1 M. O’la AL-Fawares1*, Walid Aburayyan1, Nesrin Seder2 OMA-S, Lamya AL-Tahrawe3 MNS. The correlation of gene mutation of coagulopathy cascade with elevated D-dimer levels in COVID-19 patients. J Appl Pharm Sci. 2024;14(1).
   Google Scholar
• Mlynarczyk-Bonikowska B, Kowalewski C, Krolak-Ulinska A, et al. Molecular Mechanisms of Drug Resistance in Staphylococcus aureus. Int J Mol Sci. 2022;23(15):8088. doi: 10.3390/ijms23158088
   PubMed Web of Science ®Google Scholar
• Durand G, Bes M, Meugnier H, et al. Erratum: detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France (journal of clinical Microbiology (2006) 44, 3 (847-853)). J Clin Microbiol. 2006;44(8):3053. doi: 10.1128/JCM.00871-06
   Web of Science ®Google Scholar
• Silversides JA, Lappin E, Ferguson AJ. Staphylococcal toxic shock syndrome: mechanisms and management. Curr Infect Dis Rep. 2010;12(5):392–400. doi: 10.1007/s11908-010-0119-y
   PubMedGoogle Scholar
• Mitevska E, Wong B, Surewaard BGJ, et al. The prevalence, risk, and management of methicillin-resistant Staphylococcus aureus infection in diverse populations across Canada: a systematic review. Pathogens. 2021;10(4):393. doi: 10.3390/pathogens10040393
   PubMed Web of Science ®Google Scholar
• AL-Fawares1* O, Al-Khresieh1 RO. Walid Aburayyan1, Nesrin Seder2, Hala I al-Daghistani3, Nasser El-Banna1 and EMA-T. Comparison of preservation enrichment media for long storage duration of Campylobacter jejuni §. Korean J Microbiol. 2023;59(3):192–196.
   Google Scholar
• Al-Khreshieh RO, Al-Fawares O, Em A. Campylobacter jejuni infections: epidemiology, pathophysiology, clinical manifestations and management. J Biomed Res Environ Sci. 2023;4(2):258–269. InternetAvailable from. doi: 10.37871/jbres1670
   Google Scholar
• Brawley DN, Sauer DB, Li J, et al. Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus. Nat Chem Biol. 2022;18(7):706–712. doi: 10.1038/s41589-022-00994-9
   PubMed Web of Science ®Google Scholar
• Lade H, Joo HS, Kim JS. Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus. Antibiotics. 2022;11(10):1–28. doi: 10.3390/antibiotics11101378
   Google Scholar
• Bitrus AA, Zunita Z, Bejo SK, et al. In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA). BMC Microbiol. 2017;17(1):1–10. doi: 10.1186/s12866-017-0994-6
   PubMedGoogle Scholar
• de Smalen AW, Ghorab H, Abd El Ghany M, et al. Refugees and antimicrobial resistance: a systematic review. Travel Med Infect Dis. 2017;15:23–28. doi: 10.1016/j.tmaid.2016.12.001
   PubMed Web of Science ®Google Scholar
• Malachowa N, DeLeo FR. Mobile genetic elements of Staphylococcus aureus. Cell Mol Life Sci. 2010 Sep;67(18):3057–3071. doi: 10.1007/s00018-010-0389-4
   PubMed Web of Science ®Google Scholar
• Jian Z, Zeng L, Xu T, et al. Antibiotic resistance genes in bacteria: occurrence, spread, and control. J Basic Microbiol. 2021;61(12):1049–1070. doi: 10.1002/jobm.202100201
   PubMed Web of Science ®Google Scholar
• Rasheed NA, Hussein NR. Staphylococcus aureus: An overview of discovery, characteristics, epidemiology, virulence factors and antimicrobial sensitivity. Eur J Mol Clin Med. 2021;8(03):1160–1183.
   Google Scholar
• Conly JM, Johnston BL. VISA, hetero-VISA and VRSA: the end of the vancomycin era? Can J Infect Dis. 2002;13(5):282–284. doi: 10.1155/2002/245109
   PubMedGoogle Scholar
• Shariati A, Dadashi M, Moghadam MT, et al. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Sci Rep. 2020;10(1):1–16. InternetAvailable from. doi: 10.1038/s41598-020-69058-z
   PubMed Web of Science ®Google Scholar
• Gomez-Lus ML, Aguilar L, Martin M, et al. Intracellular and extracellular killing of a penicillin-resistant, serotype-9 strain of streptococcus pneumoniae by polymorphonuclear leucocytes in the presence of sub-inhibitory concentrations of clavulanic acid. J Antimicrob Chemother. 1997;40(1):142–144. doi: 10.1093/jac/40.1.142
   PubMed Web of Science ®Google Scholar
• Goldrick B. First reported case of VRSA in the United States: an alarming development in microbial resistance. AJN Am J Nurs. 2002;102(11):17. doi: 10.1097/00000446-200211000-00015
   PubMedGoogle Scholar
• Crespo-Piazuelo D, Lawlor PG. Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) prevalence in humans in close contact with animals and measures to reduce on-farm colonisation. Ir Vet J. 2021;74(1):1–12. doi: 10.1186/s13620-021-00200-7
   PubMed Web of Science ®Google Scholar
• Khairullah AR, Ramandinianto SC, Effendi MH. A review of Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) on Bovine Mastitis. Syst Rev Pharm. 2020;11(7):172–183.
   Google Scholar
• Lakhundi S, Zhang K. Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology. Clinical Microbiology Reviews. 2018;31(4):1–103. doi: 10.1128/CMR.00020-18
   Web of Science ®Google Scholar
• Tu J, PM G. Evolutionary GEM: the evolution of methicillin-resistant Staphylococcus aureus. WURJ: HNS. 2017;8(1):8–10. doi: 10.5206/wurjhns.2017-18.22
   Google Scholar
• Elnasser ZA, Obeidat HM, Bani-Salem ME, et al. Is methicillin-resistant Staphylococcus aureus a common pathogen in ventilation-associated pneumonia?: the experience of a tertiary teaching hospital in Jordan. Med (United States). 2021;100(20):E26069. doi: 10.1097/MD.0000000000026069
   Google Scholar
• Hulla JE, Sahu SC, AW H. Nanotechnology: history and future. Hum Exp Toxicol. 2015;34(12):1318–1321. doi: 10.1177/0960327115603588
   PubMed Web of Science ®Google Scholar
• Singh S, Numan A, Somaily HH, et al. Nano-enabled strategies to combat methicillin-resistant Staphylococcus aureus. Mater Sci Eng C. 2021;129(August):112384. doi: 10.1016/j.msec.2021.112384
   PubMedGoogle Scholar
• Berk DR, Bayliss SJ. MRSA, staphylococcal scalded skin syndrome, and other cutaneous bacterial emergencies. Pediatr Ann. 2010;39(10):627–633. doi: 10.3928/00904481-20100922-02
   PubMed Web of Science ®Google Scholar
• Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. InternetAvailable from J Nanobiotechnology. 2022;20(1):262. doi: 10.1186/s12951-022-01477-8
   PubMed Web of Science ®Google Scholar
• Miller S. Nanoparticles: properties and applications. ChemXpress. 2021;13(3):143.
   Google Scholar
• Kiio TM, Park S. Physical properties of nanoparticles do matter. J Pharm Investig. 2021;51(1):35–51. InternetAvailable from. doi: 10.1007/s40005-020-00504-w
   Web of Science ®Google Scholar
• Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908–931. InternetAvailable from. doi: 10.1016/j.arabjc.2017.05.011
   Web of Science ®Google Scholar
• Oake A, Bhatt P, Pathak Y. Understanding surface characteristics of nanoparticles. In. 2019;1–17.
   Google Scholar
• Gisbert-Garzarán M, Vallet-Regí M. Nanoparticles for bio-medical applications. Nanomaterials. 2022;12(7):10–12. doi: 10.3390/nano12071189
   Web of Science ®Google Scholar
• Patil MD, Dhas SD, Moholkar AV. Green synthesis of nanocomposites. IGI Global; 2021. p. 77–100. doi: 10.4018/978-1-7998-8936-6.ch004
   Google Scholar
• Khan I, Saeed K, Khan I, et al. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019;12(7):908–931. doi: 10.1016/j.arabjc.2017.05.011
   Web of Science ®Google Scholar
• Kanwal A, Bhutta ZA, Ashar A, et al. Antimicrobial applications of nanoparticles. In: Garg R, Garg R, and Eddy N, editors. Handbook of research on green synthesis and applications of nanomaterials. IGI Global. 2022;269–288.
   Google Scholar
• Hoque Apu E, Nafiujjaman M, Sandeep S, et al. Biomedical applications of multifunctional magnetoelectric nanoparticles. Mater Chem Front. 2022;6(11):1368–1390. doi: 10.1039/D2QM00093H InternetAvailable from.
   Web of Science ®Google Scholar
• Arcos D. Nanomaterials in Biomedicine 2022. IJMS. 2023;24(10):9026. Switzerland. doi: 10.3390/ijms24109026
   Google Scholar
• Schneider-Futschik EK, Reyes-Ortega F. Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders. Pharmaceutics. 2021;13(8):1–16. doi: 10.3390/pharmaceutics13081157
   Web of Science ®Google Scholar
• Joseph TM, Kar Mahapatra D, Esmaeili A, et al. Nanoparticles: Taking a Unique Position in Medicine. Nanomaterials. 2023 Jan;13(3):574. doi: 10.3390/nano13030574
   Web of Science ®Google Scholar
• Tedla N, Ruiz J, Mody V. Synthesis, Pharmacokinetics, and Toxicity of Nano-Drug Carriers. In: Shah N, editor. Nanocarriers: Drug Delivery System. Singapore: Springer; 2021. doi: 10.1007/978-981-33-4497-6_3
   Google Scholar
• Shukla AK. Nanoparticles in Medicine. Nanoparticles Med. 2019;10(8):1–220.
   Google Scholar
• Martínez-Carmona M, Gun’ko YK, Vallet-Regí M. Mesoporous silica materials as drug delivery: “the nightmare” of bacterial infection. Pharmaceutics. 2018;10(4):1–29. doi: 10.3390/pharmaceutics10040279
   Web of Science ®Google Scholar
• Baazaoui N, Sghaier-Hammami B, Hammami S, et al. A handbook guide to better use of nanoparticles in plants. Commun Soil Sci Plant Anal. 2021 Jan 7;52(4):287–321. doi: 10.1080/00103624.2020.1836198
   Web of Science ®Google Scholar
• Maity D, Sahoo SR, Saha S. Synthesis and characterization of nanomaterials for electrochemical sensors. ACS Symp Ser. 2023;1437:193–222.
   Google Scholar
• Pawar S, Takke A. Regulatory aspects, types and bioapplications of metallic nanoparticles: a review. Curr Drug Deliv. 2023;20(7):857–883. doi: 10.2174/1567201819666220817110025
   PubMed Web of Science ®Google Scholar
• Haroon Anwar S. A brief review on nanoparticles: types of platforms, biological synthesis and applications. Res Rev J Mat Sci. 2018;6(02):109–116. doi: 10.4172/2321-6212.1000222
   Google Scholar
• Akbarzadeh H, Mehrjouei E, Abbaspour M, et al. Thermal behavior of different types of Au–pt–pd nanoparticles: dumbbell-like, three-shell, core-shell, and random-alloy. Mater Chem Phys. 2023 Oct 1;294:126955. doi: 10.1016/j.matchemphys.2022.126955
   Web of Science ®Google Scholar
• Naskar A, Kim KS. Nanomaterials as delivery vehicles and components of new strategies to combat bacterial infections: advantages and limitations. Microorganisms. 2019;7(9):356. doi: 10.3390/microorganisms7090356
   PubMed Web of Science ®Google Scholar
• Geng Z, Cao Z, Liu J. Recent advances in targeted antibacterial therapy basing on nanomaterials. Exploration. 2023;3(1):20210117. doi: 10.1002/EXP.20210117
   Google Scholar
• Natsheh IY, Elkhader MT, Al-Bakheit AA, et al. Inhibition of Acinetobacterbaumannii biofilm formation using different treatments of silica nanoparticles. Antibiotics. 2023;12(9):1365. doi: 10.3390/antibiotics12091365
   Google Scholar
• Zhang Q, Ma X, Zhao X. Hybrid bacteria system with nanomaterials for tumor therapy. Adv NanoBiomed Res. 2023;3(7):2300003. doi: 10.1002/anbr.202300003
   Google Scholar
• Liu H, Jiang Y, Wang Z, et al. Nanomaterials as carriers to improve the photodynamic antibacterial therapy. Front Chem. 2022;10(November):1–8. doi: 10.3389/fchem.2022.1044627
   Google Scholar
• Vasilev K. Antibacterial applications of nanomaterials. Nanomaterials. 2023;13(9):1530. InternetAvailable from. doi: 10.3390/nano13091530
   Web of Science ®Google Scholar
• Bai X, Yang Y, Zheng W, et al. Synergistic photothermal antibacterial therapy enabled by multifunctional nanomaterials: progress and perspectives. Mater Chem Front. 2023;7(3):355–380. doi: 10.1039/D2QM01141G InternetAvailable from.
   Web of Science ®Google Scholar
• Vallet-Regí M, Schüth F, Lozano D, et al. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev. 2022;51(13):5365–5451. doi: 10.1039/D1CS00659B
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Y, Feng N. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin Drug Deliv. 2019;16(3):219–237. doi: 10.1080/17425247.2019.1575806
   PubMed Web of Science ®Google Scholar
• Yuan J, Wu S, Duan N, et al. A sensitive gold nanoparticle-based colorimetric aptasensor for Staphylococcus aureus. Talanta. 2014;127:163–168. doi: 10.1016/j.talanta.2014.04.013
   PubMed Web of Science ®Google Scholar
• Karaman DŞ, Pamukçu A, Karakaplan MB, et al. Recent advances in the use of mesoporous silica nanoparticles for the diagnosis of bacterial infections. Int J Nanomedicine. 2021;16:6575–6591. doi: 10.2147/IJN.S273062
   PubMed Web of Science ®Google Scholar
• Miramoth NS, Di Meo C, Zouhiri F, et al. Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. ACS Nano. 2012;6(5):3820–3831. doi: 10.1021/nn204928v
   PubMed Web of Science ®Google Scholar
• Sahli C, Moya SE, Lomas JS, et al. Recent advances in nanotechnology for eradicating bacterial biofilm. Theranostics. 2022;12(5):2383–2405. doi: 10.7150/thno.67296
   PubMed Web of Science ®Google Scholar
• Cheow WS, Chang MW, Hadinoto K. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells. J Biomed Nanotechnol. 2010;6(4):391–403. doi: 10.1166/jbn.2010.1116
   PubMed Web of Science ®Google Scholar
• Ye L, Cao Z, Liu X, et al. Noble metal-based nanomaterials as antibacterial agents. J Alloys Compd InternetAvailable from: https://www.sciencedirect.com/science/article/pii/S0925838822004820. 2022;904:164091. doi: 10.1016/j.jallcom.2022.164091
   Web of Science ®Google Scholar
• Awad M, Thomas N, Barnes TJ, et al. Nanomaterials enabling clinical translation of antimicrobial photodynamic therapy. J Control Release Off J Control Release Soc. 2022 Jun;346:300–316.
   PubMed Web of Science ®Google Scholar
• Chen Y, Gao Y, Chen Y, et al. Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment. J Control Release Off J Control Release Soc. 2020 Dec;328:251–262.
   PubMed Web of Science ®Google Scholar
• Edrisi F, Baheiraei N, Razavi M, et al. Potential of graphene-based nanomaterials for cardiac tissue engineering. J Mater Chem B. 2023;11(31):7280–7299. InternetAvailable from. doi: 10.1039/D3TB00654A
   PubMed Web of Science ®Google Scholar
• Gungordu Er S, Edirisinghe M, Tabish TA. Graphene-based nanocomposites as antibacterial, antiviral and antifungal agents. Adv Healthc Mater. 2023;12(6):1–20. doi: 10.1002/adhm.202201523
   Web of Science ®Google Scholar
• Chidre P, Chavan A, Mallikarjunaiah HN, et al. Nanomaterials: Potential Broad Spectrum Antimicrobial Agents [Internet]. CNM. 2023;8(4):319–327. Available from: http://www.eurekaselect.com/article/128256
   Google Scholar
• Wang Y, Li J, Li X, et al. Graphene-based nanomaterials for cancer therapy and anti-infections. Bioact Mater. 2022;14:335–349. InternetAvailable from: https://www.sciencedirect.com/science/article/pii/S2452199X22000597
   PubMed Web of Science ®Google Scholar
• Zhou H, Zou F, Koh K, et al. Antibacterial activity of graphene-based nanomaterials. Adv Exp Med Biol. 2022;1351:233–250.
   PubMedGoogle Scholar
• Marković ZM, Kepić DP, Matijašević DM, et al. Ambient light induced antibacterial action of curcumin/graphene nanomesh hybrids. RSC Adv. 2017;7(57):36081–36092. doi: 10.1039/C7RA05027E
   Web of Science ®Google Scholar
• Zhou X, Hao Y, Yaxin L, et al. MXenes: An emergent materials for packaging platforms and looking beyond. Nano Select. 2022;3(7):1123–1147. doi: 10.1002/nano.202200023
   Google Scholar
• Yaragalla S, Bhavitha KB, Athanassiou A. A review on graphene based materials and their antimicrobial properties. Coatings. 2021;11(10):1–18. doi: 10.3390/coatings11101197
   Web of Science ®Google Scholar
• Dwivedi N, Dhand C, Kumar P, et al. Emergent 2D materials for combating infectious diseases: the potential of MXenes and MXene–graphene composites to fight against pandemics. Mater Adv. 2021;2(9):2892–2905. doi: 10.1039/D1MA00003A
   Google Scholar
• Amara U, Hussain I, Ahmad M, et al. 2D MXene‐Based Biosensing: A Review. Small. 2022;19(2). Nov 1. doi: 10.1002/smll.202205249
   PubMed Web of Science ®Google Scholar
• Rizi KS. Mxene nanosheets as a novel nanomaterial with antimicrobial applications: a literature review. J Mol Struct. 2022;1262:132958. InternetAvailable from: https://www.sciencedirect.com/science/article/pii/S0022286022006275
   Web of Science ®Google Scholar
• Li H, Fan R, Zou B, et al. Roles of MXenes in biomedical applications: recent developments and prospects. J Nanobiotechnology. 2023;21(1):1–39. InternetAvailable from. doi: 10.1186/s12951-023-01809-2
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang Y, Liu M, et al. Two-dimensional titanium carbide MXene produced by ternary cations intercalation via structural control with angstrom-level precision. iScience. 2022;25(12):105562. InternetAvailable from: https://www.sciencedirect.com/science/article/pii/S258900422201834X
   PubMed Web of Science ®Google Scholar
• Rosenkranz A, Righi MC, Sumant AV, et al. Perspectives of 2D MXene tribology. Adv Mater. 2023;35(5). doi: 10.1002/adma.202207757
   Web of Science ®Google Scholar
• Ramezani Farani M, Nourmohammadi Khiarak B, Tao R, et al. 2D MXene nanocomposites: electrochemical and biomedical applications. Environ Sci Nano. 2022 Jan 1;9(11):4038–4068. doi: 10.1039/D2EN00527A
   Web of Science ®Google Scholar
• Marchwiany ME, Birowska M, Popielski M, et al. Surface-related features responsible for cytotoxic behavior of mxenes layered materials predicted with machine learning approach. Materials. 2020;13(14):1–17. doi: 10.3390/ma13143083
   Web of Science ®Google Scholar
• Lim GP, Soon CF, Ma NL, et al. Cytotoxicity of MXene-based nanomaterials for biomedical applications: a mini review. Environ Res InternetAvailable from. 2021;201:111592. doi: 10.1016/j.envres.2021.111592
   PubMed Web of Science ®Google Scholar
• Iravani S, Varma RS. Smart MXene quantum dot-based nanosystems for biomedical applications. Nanomaterials. 2022;12(7):1–16. doi: 10.3390/nano12071200
   Web of Science ®Google Scholar
• Cheah YJ, Buyong MR, Mohd Yunus MH. Wound healing with electrical stimulation technologies: a review. Polymers. 2021;13(21):1–21. doi: 10.3390/polym13213790
   Web of Science ®Google Scholar
• Jang JH, Lee EJ. Influence of MXene particles with a stacked-lamellar structure on osteogenic differentiation of human mesenchymal stem cells. Materials. 2021;14(16):4453. doi: 10.3390/ma14164453
   PubMed Web of Science ®Google Scholar
• Qiang M, Wu J, Zhang H, et al. Ag/cu-chitosan composite improves laundry hygiene and reduces silver emission in washing machines. Polymers. 2023;15(3):695. doi: 10.3390/polym15030695
   PubMed Web of Science ®Google Scholar
• Li Q, Wang S, Jin X, et al. The application of polysaccharides and their derivatives in pigment, barrier, and functional paper coatings. Polymers. 2020;12(8):1837. doi: 10.3390/polym12081837
   PubMed Web of Science ®Google Scholar
• Hadidi N, Mohebbi M. Anti-infective and toxicity properties of carbon based materials: graphene and functionalized carbon nanotubes. Microorganisms. 2022;10(12):2439. doi: 10.3390/microorganisms10122439
   PubMed Web of Science ®Google Scholar
• Smirnova VV, Chausov DN, Serov DA, et al. A novel biodegradable composite polymer material based on plga and silver oxide nanoparticles with unique physicochemical properties and biocompatibility with mammalian cells. Materials. 2021;14(22):6915. doi: 10.3390/ma14226915
   PubMed Web of Science ®Google Scholar
• Mizwari Z, Oladipo A, Yilmaz E. Chitosan/Metal oxide nanocomposites: synthesis, characterization, and antibacterial activity. Int J Polym Mater. 2021 Feb 22;70(6):383–391. doi: 10.1080/00914037.2020.1725753
   Web of Science ®Google Scholar
• Cai J, Liu R. Introduction to antibacterial biomaterials. Biomater Sci. 2020;8(24):6812–6813. InternetAvailable from. doi: 10.1039/D0BM90100H
   PubMed Web of Science ®Google Scholar
• Shahbazi Y, Shavisi N. Current advancements in applications of chitosan based nano-metal oxides as food preservative materials. Nanomed Res J. 2019;4(3):122–129. doi:10.22034/NMRJ.2019.03.001
   Google Scholar
• Shahbazi Y, Shavisi N. Current advancements in applications of chitosan based nano-metal oxides as food preservative materials. Nanomedicine Res J. 2019;4(3):122–129. InternetAvailable from. http://www.nanomedicine-rj.com/article_36898.html
   Google Scholar
• Lu MM, Wang QJ, Chang ZM, et al. Synergistic bactericidal activity of chlorhexidine-loaded, silver-decorated mesoporous silica nanoparticles. Int J Nanomedicine. 2017;12:3577–3589. doi: 10.2147/IJN.S133846
   PubMed Web of Science ®Google Scholar
• Narayan R, Nayak UY, Raichur AM, et al. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10(3):1–49. doi: 10.3390/pharmaceutics10030118
   Web of Science ®Google Scholar
• Colilla M, Vallet-Regí M. Targeted stimuli-responsive mesoporous silica nanoparticles for bacterial infection treatment. Int J Mol Sci. 2020;21(22):8605–8632. doi: 10.3390/ijms21228605
   PubMed Web of Science ®Google Scholar
• Borodina T, Kostyushev D, Zamyatnin AA, et al. Nanomedicine for treating diabetic retinopathy vascular degeneration. IJTM. 2021;1(3):306–322. doi: 10.3390/ijtm1030018
   Google Scholar
• Grunberger JW, Ghandehari H. Layer-by-layer Hollow Mesoporous silica nanoparticles with tunable degradation profile. Pharmaceutics. 2023;15(3):832. doi: 10.3390/pharmaceutics15030832
   PubMed Web of Science ®Google Scholar
• Sharma SK, Sharma AR, Pamidimarri SDVN, et al. Bacterial compatibility/toxicity of biogenic silica (B-SiO2) nanoparticles synthesized from biomass rice husk ash. Nanomaterials. 2019;9(10):1–10. doi: 10.3390/nano9101440
   Web of Science ®Google Scholar
• Kang SH, Lee YK, Park IS, et al. Biomimetic gold nanoshell-loaded macrophage for photothermal biomedicine. Bio Med Res Int. 2020;2020:1–14. doi: 10.1155/2020/5869235
   Google Scholar
• Danylenko S, Marynchenko L, Bortnyk V, et al. Use of highly dispersed silica in biotechnology of complex probiotic product based on bifidobacteria. Innov Biosyst Bioeng [Internet]. 2022; Available from: http://ibb.kpi.ua/article/view/256179
   Google Scholar
• Zakiyyah SN, Rakhmawaty Eddy D, Firdaus M, et al. Application of gold silica nanocomposites in electrochemical biosensors: a review. pendipa jurnal pendik sains. 2021;5(2):122–132. doi: 10.33369/pendipa.5.2.122-132
   Google Scholar
• Sprenger S. Nanosilica-toughened epoxy resins. Switzerland: MDPI AG; 2020.
   Google Scholar
• Antimicrobial E, Activities P, Al-Askar AA, et al. Green biosynthesis of zinc oxide nanoparticles using pluchea. Molecules. 2023;28:4679. doi:10.3390/molecules28124679
   PubMed Web of Science ®Google Scholar
• Mohamed MBED, Abo El-Ela FI, Mahmoud RK, et al. Cefotax-magnetic nanoparticles as an alternative approach to control methicillin-resistant Staphylococcus aureus (MRSA) from different sources. Sci Rep. 2022;12(1):1–10. doi: 10.1038/s41598-021-04160-4
   PubMed Web of Science ®Google Scholar
• Fan F, Saha S, Hanjaya-Putra D. Biomimetic hydrogels to promote wound healing. Front Bioeng Biotechnol. 2021;9(September):1–24. doi: 10.3389/fbioe.2021.718377
   Google Scholar
• Singh B, Vuddanda PR, V MR, et al. Cefuroxime axetil loaded solid lipid nanoparticles for enhanced activity against S. aureus biofilm. Colloids Surf B Biointerfaces. 2014;121:92–98. doi: 10.1016/j.colsurfb.2014.03.046
   PubMed Web of Science ®Google Scholar